We investigated the mechanisms of excitation-contraction (EC) coupling in human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and fetal ventricular myocytes (hFVMs) using patch-clamp electrophysiology and confocal microscopy. We tested the hypothesis that 
] i transients in hESC-CMs required Ca 2+ entry through L-type Ca 2+ channels, as evidenced by the elimination of such transients by either removal of extracellular Ca 2+ or treatment with diltiazem, an L-type channel inhibitor. Ca 2+ release from the SR also contributes to the [Ca 2+ ] i transient in these cells, as evidenced by studies with drugs interfering with either SR Ca 2+ release (i.e. ryanodine and caffeine) or reuptake (i.e. thapsigargin and cyclopiazonic acid). As in adult ventricular myocytes, membrane depolarization evoked large L-type Ca 2+ currents (I Ca ) and corresponding whole-cell [Ca 2+ ] i transients in hESCCMs and hFVMs, and the amplitude of both I Ca and the [Ca 2+ ] i transients were finely graded by the magnitude of the depolarization. hESC-CMs exhibit a decreasing EC coupling gain with depolarization to more positive test potentials, ''tail'' [Ca 2+ ] i transients upon repolarization from extremely positive test potentials, and co-localized ryanodine and sarcolemmal Ltype Ca 2+ channels, all findings that are consistent with the local control hypothesis. Finally, we recorded Ca 2+ sparks in hESC-CMs and hFVMs. Collectively, these data support a model in which tight, local control of SR Ca 2+ release by the I Ca during EC coupling develops early in human cardiomyocytes.
Introduction
Human embryonic stem cells (hESCs) can be induced to differentiate in vitro into cardiomyocytes (hESC-CMs). These cells express expected cardiac markers and exhibit spontaneous action potentials (APs), [Ca 2+ ] i transients, and contractile activity. At present, however, the mechanisms underlying excitation-contraction (EC) coupling in hESC-CMs are incompletely understood. Addressing this issue is critical for two fundamental reasons. First, hESC-CMs represent a unique model system in which to study the development of EC coupling in early human myocardium. Second, because of their tremendous expandability and unquestioned cardiac potential, hESC-CMs have considerable promise for eventual application in cell-based cardiac repair (for review, see refs [1, 2] ). However, because hESC-CMs should be well-matched to host adult human ventricular myocardium to optimize hostgraft electromechanical integration and minimize the risk of arrhythmias, the development of any cell therapies based on hESC-CMs must be preceded by a thorough investigation of the biophysical properties of these cells.
Unlike in hESC-CMs, the mechanisms underlying EC coupling in mammalian adult ventricular myocytes have been the subject of intense investigation for many years and so are comparatively well-understood (for review, see refs [3, 4] ). Studies with adult cardiomyocytes have led to the formulation of the local control model of EC coupling [5] [6] [7] [8] [9] . In this model, brief openings of voltagegated L-type Ca 2+ channels during the AP allow a small amount of Ca 2+ to enter the cardiac cytoplasm. This Ca 2+ influx causes a local [Ca 2+ ] i increase that rapidly (,1 ms) activates nearby sarcoplasmic reticulum (SR) Ca 2+ release channels (i.e. ryanodine receptors, RyRs) by the mechanism of Ca 2+ -induced Ca 2+ release (CICR) [10] . The simultaneous activation of a small number of RyRs allows Ca 2+ stored in the lumen of the SR to flow into the cardiomyocyte cytoplasm causing a local increase in [Ca 2+ ] i . These local Ca 2+ release events, termed 'Ca 2+ sparks', are considered the elementary Ca 2+ release events of EC coupling [6] . Ca 2+ sparks can occur spontaneously, or they can be activated by the L-type Ca 2+ current (I Ca ) [5, 11, 12] ] i to resting levels [13] . A central tenet of this model is that the amplitude of the [Ca 2+ ] i is graded by the amplitude of I Ca [8] . Although the mechanisms underlying EC coupling in hESCCMs are incompletely understood, in principle one can envision four potential mechanistic models for the development of a global, whole-cell [Ca 2+ ] i transient during an AP in these cells. Model 1 involves a mechanism similar to that of turtle [14] , frog [15] , and dogfish [16] 
Materials and Methods

Differentiation of hESC-CMs
For all experiments, H7 hESCs [23] were differentiated into cardiomyocytes using our recently reported directed cardiac differentiation protocol [24] . In brief, hESCs were expanded in the undifferentiated state on Matrigel (BD Biosciences, San Jose, CA) coated substrates using mouse embryonic fibroblast conditioned medium (MEF-CM) [25] . Prior to induction of cardiogenesis, hESCs were enzymatically dispersed, replated onto Matrigelcoated surfaces in a high-density monolayer culture, and then maintained for an additional 6 days in MEF-CM. To induce cardiac differentiation, MEF-CM is replaced by RPMI-B27 medium (Invitrogen, Carlsbad, CA) supplemented with the following cytokines: 100 ng/ml human recombinant activin A (R&D Systems, Minneapolis, MN) for 24 hours, followed by 10 ng/ml human recombinant bone morphogenenetic protein-4 (BMP-4, R&D Systems) for 4 days. This medium is then exchanged for RPMI-B27 without supplementary cytokines on every second day for an additional 10 days. Widespread spontaneous beating activity is typically observed by 9-12 days following induction with activin A. On day 14 post-induction, cells are enzymatically dispersed (with dispase) and re-plated onto polyethylenimine-and gelatin-coated glass coverslips for calcium imaging, electrophysiological recordings, or immunofluorescence 3-7 days later. We routinely immunostained comparably prepared cultures and, consistent with our prior report describing this method [24] , found the majority of resultant cells to be comprised of cardiomyocytes (5968% positive for the striated muscle marker sarcomeric actin, data not shown).
Dissociation of human fetal ventricular myocytes
Human fetal hearts (90-110 days gestational age) were obtained from the University of Washington Birth Defects Research Laboratory under a waiver from the University's Institutional Review Board (IRB) for Human Subjects. The IRB determined that this work, which involved anonymous human biological materials received from this depository, is not considered human subjects research (IRB Determination # 08-0062-N). The NIHfunded Birth Defects Research Laboratory tissue distribution program has been separately approved by the IRB (approval #96-1825-A13) and operates in fully compliance with all relevant state and federal laws and regulations. All donors provide written informed consent prior to donating tissues to this depository, and all donated tissues would otherwise be discarded. Ventricular myocytes were then dissociated from these fetal hearts using enzymatic methods modified from those described by UfretVincenty et al. [26] . In brief, after transport in ice-cold DMEM, each heart was retrogradely perfused with oxygenated Ca 2+ -free Tyrode's solution (37uC, pH 7.4) for 5 minutes, followed by a switch to a solution also containing 1% collagenase I (Worthington Biochemical, Lakewood, NJ), 0.01% protease, and 0.08 mM CaCl 2 . After approximately 10 minutes of digestion, the left ventricular tissue was removed, minced and filtered through nylon mesh. The resultant dissociated ventricular myocytes were maintained in Dulbecco's MEM at 25uC for up to 4 hours before use.
Ca
2+ imaging
We ] i that did not involved patch-clamping (i.e. Ca 2+ sparks, SR Ca 2+ load in paced and un-stimulated cells), myocytes were loaded with the membrane permeable acetoxymethyl-ester form of Fluo-4 (Fluo-4 AM) as previously described [27] . Coverslips containing the dye-loaded hESC-CMs or hFVMs were mounted in a chamber and superfused at a rate of 1 ml/min with solution A (see Table 1 software written in IDL language (Research Systems, Boulder, CO, USA). Ca 2+ sparks were identified using a computer algorithm similar to the one described by Cheng et al. [28] . The amplitude of the [Ca 2+ ] i transient evoked by the application of a Ca 2+ -and Na + -free (substituted with N-methyl-D-glucamine) solution containing 20 mM caffeine (1 s; via a picospritzer) was used as an indicator of SR Ca 2+ content [29] . To ensure steadystate SR Ca 2+ load, cells were subjected to a minimum of 10 preconditioning pulses (1 Hz) before caffeine was applied. Calibration of fluorescence signals was performed using the 'pseudo-ratio' equation [6] .
Patch-clamp electrophysiology
I Ca was elicited at 1 Hz and recorded using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Union City, CA) operated in voltage-clamp mode. During I Ca recordings, cells were superfused with solution B (see Table 1 below) at 25u C. The pipette solution used in these experiments was solution C (also in Table 1 ). To inactivate the fast sodium current, cells were depolarized via a 500 ms duration ''ramp'' from a holding potential of 270 mV to 250 mV and then held at the latter potential for an additional 200 msec. To activate I Ca , cells were next depolarized with a 200 ms duration step from 250 mV to any of range of voltages from 240 to +100 mV. For some experiments, [Ca 2+ ] i transients were simultaneously recorded either during the depolarization step or after repolarization to a 270 mV holding potential, using the techniques detailed in the preceding section. The whole-cell capacitance was determined using the charging time ('RC') constant that resulted from 5 mV depolarizing pulses from a holding potential of 270 mV. The capacitance of hESC-CMs and hFVMs measured 24.663.3 pF (n = 15) and 20.364.6 pF (n = 6), respectively. The series resistance compensation circuitry of the Axopatch 200B was used in all voltage-clamp experiments to compensate for about 60% of the series resistance. Signals were digitized and stored on a computer running the pCLAMP 8 software suite (Axon Instruments), and analysis of electrophysiological records was performed using the CLAMPFIT module of pCLAMP 8. I Ca was normalized to cell capacitance.
Field-stimulation
Field stimulation was performed via two platinum wires (0.5 cm separation) placed at the bottom of a customized perfusion chamber. An IonOptix Myopacer (IonOptix Corp, Milton, MA, USA) stimulator was used to deliver square voltage pulses (4 ms duration) with amplitude of 1.56threshold at a frequency of 1 Hz.
Immunocytochemistry
Immunostaining was performed as previously described [24, 30] , using antibodies directed against the RyR2 channel (mouse monoclonal antibody, Affinity Bioreagents, Rockford, IL, used at a 1:1000 dilution) and Cav1.2, the a 1c subunit of the L-type Ca channel (rabbit polyclonal antibody, Sigma, used at a 1:500 dilution). In brief, cells were fixed with 2% paraformaldehyde, permeabilized with the addition of 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 10 minutes, quenched in an isotonic solution of 50 mM glycine in diluted PBS for 10 minutes, and then blocked with 1.5% normal goat serum in PBS at 4u C overnight. The aforementioned primary antibodies were then applied serially (each overnight at 4u C, also in 1.5% normal goat serum in PBS), followed by detection with either an Alexa-488-conjugated goat anti-mouse or Alexa-594-conjugated goat antirabbit secondary antibody (Molecular Probes, Eugene, OR). Images were acquired using the Nikon Swept Field confocal system described above with a 1006 (1.49 NA) lens. Alexa-488
and Alexa-594 were excited with the 488 nm and 561 nm laser lines of this system. Fluorescence emission signals from these indicators were collected sequentially and separated using appropriate filter sets. Images were collected at 0.25 mm intervals in the z-axis. Co-localization analysis and volumetric reconstructions of confocal three-dimensional images stacks were performed using Elements software (Nikon).
Statistics
All data groups were submitted to a D'Agostino & Pearson omnibus test to determine whether they had a normal (i.e. bellshaped) distribution. Parametric data are presented as mean6-standard error of the mean (SEM). Non-parametric data are presented as median and range. Two-sample comparisons were made using a Mann-Whitney or Student's t-test. A p value less than 0.05 was considered significant. Asterisks (*) used in the figures indicate a significant difference between groups. (Figure 2A and B) . Thapsigargin treatment decreased the amplitude of the evoked [Ca 2+ ] i transient to 21610% of control (n = 7; p,0.05). We next repeated this experiment using the reversible SERCA inhibitor cyclopiazonic acid (CPA, 10 mM). Figure 2C shows AP-evoked [Ca 2+ ] i transients from a representative hESC-CM under control conditions, during CPA treatment, and after the SERCA pump inhibitor was washed out. CPA decreased [Ca 2+ ] i transient amplitude to 30610% (n = 7; p,0.01), but this effect was partially reversed following drug washout (to 5769% of baseline, n = 7; p,0.01). Taken collectively with the data in Figure 1 ] i transient varied with the magnitude of the test membrane potential in both cell types (Figure 3) . Interestingly, the amplitude of I Ca and the [Ca 2+ ] i transient were remarkably similar in hESC-CMs and hFVMs at all membrane potentials examined. At 0 mV, I Ca density was 9.161.7 (n = 7 cells) and 11.661.6 (n = 6 cells; p = 0.067) pA/pF in hESC-CMs and hFVMs, respectively. The amplitude of the [Ca 2+ ] i transient at the same potential was 1097697 and 902677 nM (p = 0.15) in hESC-CMs and hFVMs, respectively.
Results
Ca
Moreover, as previously reported in adult ventricular myocytes [32, 33] , the voltage dependencies of I Ca ( Figure 3B ) and the [Ca 2+ ] i transients ( Figure 3C ) were bell-shaped, gradually increasing in amplitude as the cell was depolarized from 240 to 0 mV. Depolarization to more positive potentials (.0 mV) evoked progressively smaller I Ca and [Ca 2+ ] i transients, likely due to a reduction in the driving force for Ca 2+ influx. To quantify changes in the sensitivity of the SR to the trigger I Ca , we calculated the EC coupling ''gain'' (defined as the ratio of the [Ca 2+ ] i transient amplitude to the I Ca current density [12, 34] ) elicited with each voltage step. One of the predictions of the local control hypothesis (i.e. model 4) is that this gain factor will be high at negative potentials (e.g. 240 mV, where I Ca is small, but the driving force for Ca 2+ entry via single L-type Ca 2+ channels is large) but will decrease with depolarization to increasingly positive test potentials (e.g. 0 mV, where I Ca amplitude is maximal, but the amplitude of unitary L-type Ca 2+ current is comparatively small). This prediction holds true in mammalian adult ventricular myocytes [5, 12, 34] , and we found that it also applies to hESC-CMs and hFVMs ( Figure 3E ).
When adult ventricular are depolarized to highly positive test potentials close to the Nernst equilibrium potential for Ca 2+ (,+120 mV), L-type Ca 2+ channels open, but the Ca 2+ influx through these channels is low due to a weak driving force. However, upon repolarization from such extremely positive test potentials (e.g. repolarization from +100 mV to 270 mV), there is a rapid increase in driving force, and a ''tail'' I Ca is evoked. Because L-type Ca 2+ channels deactivate rapidly (t of deactivation,1 ms), these tail I Ca currents are short-lived. In adult ventricular myocytes, tail I Ca currents can also induce [Ca 2+ ] i transients, a phenomenon that has been attributed to CICR initiated by the Ca 2+ influx during repolarization [32, 35, 36] . The exhibition of tail [Ca 2+ ] i transients is considered strong evidence for the local control hypothesis, as the extremely brief tail I Ca is thought to allow only a small amount of Ca 2+ influx and so is only able to activate RyRs within a tight, local domain. The presence of tail [Ca 2+ ] i transients also distinguishes cardiac-type EC coupling from that in skeletal muscle, which operates on a charge-coupled mechanism and so repolarization does not elicit SR Ca 2+ release [37] . We found that hESC-CMs exhibited robust tail [Ca 2+ ] i transients in response to repolarization to 270 mV following a voltage step to +100 mV ( Figure 4A ). Of note, both these tail [Ca 2+ ] i transients and [Ca 2+ ] transients elicited during a voltage step to peak I Ca (i.e. a test potential of 0 mV) were largely eliminated by treatment with ryanodine (10 mM), an effect that indicates a significant contribution by release from RyR-gated SR Ca 2+ stores ( Figure 4B ). In particular, ryanodine reduced the amplitude of tail [Ca 2+ ] i transients (evoked by repolarization from +100 mV to 270 mV) from a baseline of 945637 nM to 250610 nM, and it reduced the amplitude of [Ca 2+ ] transients (evoked by a depolarizing step to 0 mV) from 853652 nM to 26968 nM (n = 6 cells per condition).
Collectively, these data indicate that Ca 2+ release from the SR is graded by the amplitude of I Ca , likely via local Ca 2+ signaling between closely apposed L-type Ca 2+ channels and RyRs in hESC-CMs (i.e. model 4). Co-localization of ryanodine receptors and L-type Ca 2+ channels in hESC-CMs
Another testable prediction of the local control model of EC coupling is that L-type Ca 2+ channels (Cav1.2) and ryanodine receptors (RyRs) are co-localized within specific domains near the sarcolemma. To test this hypothesis in hESC-CMs, we examined the subcellular distribution of type 2 RyRs (RyR2s) and L-type Ca 2+ channels in hESC-CMs using confocal immunofluorescence approaches. As illustrated by Figure 5A , we observed punctate immunoreactivity for L-type Ca 2+ channels throughout the sarcolemma of hESC-CMs. Interestingly, L-type Ca 2+ channels (red) and RyR2s (green) were co-localized within small clusters near the surface of the cell ( Figure 5B) . The diameter at 50% amplitude of L-type Ca 2+ channels and RyR2 clusters was 1.260.1 mm (n= 55) and 1.060.1 mm (n = 41), respectively. We performed quantitative colocalization analysis of L-type Ca 2+ and RyR2-associated fluorescence on a pixel-by-pixel basis. The statistical significance of the colocalization of these two proteins is supported by Mander's overlap and Pearson correlation values of +0.88 and +0.83, respectively. These data indicate that L-type Ca 2+ channels are co-localized with RyR2s within small sarcolemmal clusters in hESC-CMs.
Spontaneous Ca 2+ sparks in hESC-CM and hFVMs
To better understand the mechanisms underlying Ca 2+ release from the SR of hESC-CMs and hFVMs, we asked whether these cell types exhibit Ca 2+ sparks, the elementary release events during ECcoupling. In fact, spontaneous Ca 2+ sparks were routinely observed in both hESC-CMs and hFVMs. Representative sparks and associated parameters from both cell types are depicted in Figure 6 , and a summary of our comparative analysis of Ca 2+ sparks in these cells is presented in Table 2 . The width at 50% peak amplitude and T 50 were similar in both cell types (p.0.05, n = 36 in hESC-CMs, n = 86 in hFVMs). Interestingly, however, the Ca 2+ spark rate (defined as the number of Ca 2+ sparks per sec per cell) was nearly four-fold higher in hFVMs (n = 7) than in hESC-CMs (n = 10; p,0.01). Ca 2+ spark amplitude and time-to-peak were also greater in hFVMs (n = 86 events) than in hESC-CMs (n = 36 events, p,0.05).
Finally, because SR Ca 2+ load modulates Ca 2+ spark activity [38] , we also examined this parameter in hESM-CMs and hFVMs, using the amplitude of a caffeine-induced [Ca 2+ ] i transient as an indicator of SR Ca 2+ load (Figure 7 ). To ensure steady-state SR Ca 2+ loading, caffeine (20 mM) was applied after conditioning each cell with a train of ten APs. We found that the amplitude of the caffeine-induced [Ca 2+ ] i transient was higher in hFVMs (6.360.3 F/F 0 , n = 6) than in hESC-CMs (5.860.3 F/F 0 , n = 8, p = 0.004), suggesting that steady-state SR Ca 2+ load is greater in hFVMs than in hESC-CMs.
Discussion
In adult ventricular myocytes, activation of SR Ca 2+ release during the AP occurs at special structures named Ca 2+ release units (CRUs) in which L-type Ca 2+ channels are in close proximity (about 10-12 nm) to RyRs in the junctional SR [39] . The cytosolic volume in this junctional space is small. Brief openings (,1 ms) 
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2+ exchanger, and RyR2, there has been considerable controversy as to the fundamental mechanisms of excitationcontraction coupling in these cells [43] [44] [45] [46] . For example, Dolnikov et al [47] concluded that essentially all of the [Ca 2+ ] i transient rise observed in hESC-CMs results from trans-sarcolemmal entry via calcium channels and that these cells have little or no release from internal Ca 2+ stores. By contrast, Satin et al [48] recently reported that hESC-CMs do exhibit caffeine-and ryanodine-sensitive SR Ca 2+ stores, even at early stages (e.g. as soon as 2 days following the appearance of spontaneous beating activity). A third group, Liu et al. [45] , also found evidence for functional SR Ca 2+ stores in hESC-CMs, albeit only in a minority of cardiomyocytes. Of note, all three groups largely relied on hESC-CMs generated using the ''historical'' method of embryoid body differentiation (i.e. the formation of spontaneously differentiating three-dimensional aggregates in high fetal calf serum (FCS)). The present study is the first to examine intracellular Ca 2+ signaling in hESC-CMs resulting from our recently reported guided differentiation protocol (involving serial activin A and BMP-4 under serum-free, monolayer culture conditions). This method results in preparations of substantially higher cardiac purity (typically .60% cardiomyocytes, versus ,1% cardiomyocytes via embryoid body differentiation), greatly facilitating biophysical studies with hESC-CMs, but it could in principle result in cardiomyocytes with a different functional phenotype. For example, FCS is known to retard cardiac differentiation [49] , so its elimination in our protocol could conceivable promote a greater degree of maturation.
Here, we report that that hESC-CMs produce Ca 2+ sparks and exhibit robust I Ca and [Ca 2+ ] i transients. I Ca density in hESC-CM is similar to that of hFVM as well as adult human, mouse, and rat ventricular myocytes [31, 50, 51] . Note that the capacitance -an indicator of cell surface area -of hESC-CMs and hFVMs is ,20-25 pF, which is roughly 5-10-fold smaller than that of adult ventricular myocytes (which typically range between 100-200 pF [52] ). Collectively, these data suggest that I Ca density is established early in the differentiation of ventricular cardiomyocytes and that, during development, myocyte hypertrophy is accompanied by a concomitant increase in L-type Ca 2+ channel expression (presumably Cav1.2) that leads to a relatively stable I Ca density throughout development.
The findings in our study, which is the first to directly examine the relationship between I Ca and [ ] i transients were evoked by tail I Ca during repolarization from +100 mV to 270 mV. Fifth, EC coupling gain is larger at negative potentials where I Ca is small (i.e. 240 mV), but the driving force for Ca 2+ influx is large, than at more positive potentials in which I Ca is maximal (i.e. 0 mV), but the driving force for Ca 2+ entry is lower. Sixth, RyR2 and L-type Ca 2+ channels co-localize in specific regions of the sarcolemma of hESC-CMs. Collectively, these findings strongly indicate that the establishment of tight, local control of EC coupling is an early event in the development of human cardiomyocytes. Note that this conclusion distinguishes hESC-CMs from developing cardiomyocytes in model species, including mice [17, [20] [21] [22] , rats [53, 54] , and rabbits [55, 56] , in which such adult-like mechanisms of EC coupling have not generally been observed. Future studies to further investigate these species differences are clearly warranted (and ideally should include larger, slower-rated animal models, which we speculate may more closely approximate developing human cardiomyocytes).
As with the magnitude and kinetics of the I Ca , we found that the amplitude of the evoked [Ca 2+ ] i transient in hESC-CMs was similar to that of hFVMs as well as adult human [57] , mouse [27] , and rat ventricular myocytes [6] . Our data suggest that a 2+ sparks, and their sparks were similar in amplitude, duration, and spatial spread to those reported in adult cardiomyocytes [6, 58] . Our data suggests that, just as I Ca appears fairly early in the development of ESCCMs [59, 60] , hESC-CMs at an early stage of maturation possess functional CRUs capable of producing adult-like Ca 2+ sparks. We infer that this early development of CRUs is also likely to be true in human heart development in situ. Ca 2+ spark rate was lower in hESC-CMs than in hFVMs presumably because SR Ca 2+ load was higher in hESC-CMs than in hFVMs these cells [38] . The latter data raise an interesting conundrum: How can hFVMs have larger SR Ca 2+ load than hESC-CMs, but Ca 2+ sparks and wholecell [Ca 2+ ] i of similar amplitude? Our data do not provide an answer to this difficult question. One intriguing possibility is that the number of RyRs underlying a Ca 2+ spark differs between hESC-CMs and hFVMs. Thus, while the total Ca 2+ flux through each RyR channel may be smaller (due to lower SR Ca 2+ load) in hESC-CMs than in hFVMs, a larger number of these channels per CRU in hESC-CMs results in Ca 2+ sparks of similar amplitude in both cell types. If correct, this implies that, while hESC-CMs have functional CRUs capable of producing Ca 2+ sparks, the development of these units is likely incomplete. Future studies should examine the mechanisms underlying the development of CRUs and Ca 2+ sparks in hESC-CMs in more detail.
The Kamp [61] and Mummery [46] groups have reported that hESC-CMs are electrophysiologically diverse and include myocytes with distinct pacemaker/nodal-like and ''working'' (atrial and ventricular chamber-like) AP properties. While it would be of considerable interest to correlate hESC-CM cardiac subtype with the mechanisms of EC-coupling, this is unfortunately technically challenging and so was not performed in the present study. However, in separate current-clamp studies using the same cell preparations, we found that ,70% (11 of 16) of cells exhibited a ''working'', ventricular-like AP phenotype, with the balance showing nodal-like APs (data not shown). Thus, we expect that the vast majority of recordings in this study were obtained with ventricular-like cardiomyocytes. Interestingly, unlike our AP data, we found the EC-coupling parameters in these cells to be highly homogenous (i.e. with a unimodal distribution), inviting speculation that EC-coupling mechanisms may be similar across cardiac subtypes at this developmental stage. We plan to revisit this issue in more detail in future work.
To conclude, our data clearly indicate that there is a close relationship between I Ca and [Ca 2+ ] i in hESC-CMs. Furthermore, our findings support the view that tight, presumably local, control of EC coupling is an early event in human cardiac development. Note that this conclusion distinguishes hESC-CMs from developing cardiomyocytes in model species, including mice [17, [20] [21] [22] , rats [53, 54] , and rabbits [55, 56] , in which such adult-like mechanisms of EC coupling have not generally been observed. Finally, based on our findings, we speculate that it is total number of L-type Ca 2+ channels and RyRs-not their density or coupling strength-that changes during the maturation of human cardiomyocytes.
